Loading...
Market
How will Johnson & Johnson's stock perform post-settlement approval by December 31, 2024?
2
Resolution / Starting Odds
Increase by 10% or more • 25%
Increase by less than 10% • 25%
No significant change • 25%
Decrease • 25%
Stock market data from financial platforms like Bloomberg or Yahoo Finance
Story
Johnson & Johnson Secures Backing for $6.5 Billion Baby Powder Settlement
Aug 12, 2024, 06:49 PM
Johnson & Johnson has received plaintiff backing for a $6.5 billion settlement plan to resolve thousands of lawsuits. These lawsuits have been filed by individuals who claim that the company's baby powder caused cancer. The approval marks a significant step forward for Johnson & Johnson in addressing these legal challenges.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Approved without modifications • 25%
Approved with modifications • 25%
Rejected • 25%
Other • 25%
Above $175 • 25%
Between $150 and $175 • 25%
Between $125 and $150 • 25%
Below $125 • 25%
Yes • 50%
No • 50%
Settlement accepted by all plaintiffs • 25%
Settlement accepted by majority but not all plaintiffs • 25%
Settlement rejected by majority of plaintiffs • 25%
Settlement renegotiated • 25%
Outperform • 25%
Match • 25%
Underperform • 25%
Significantly underperform • 25%
